First Choice Neurology

Jeffrey Gelblum MD

Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients

By Jeffrey Gelblum, MD As a practicing neurologist with over 25 years of experience treating Alzheimer’s disease, I strongly oppose the proposed intention of Centers for Medicare & Medicaid Services (CMS) to restrict coverage of anti-amyloid antibody therapy to only those patients who must participate in an approved hospital-based clinical trial (Coverage with Evidence Development, …

Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients Read More »

COVID-19: Roadmap to Reopening

First Choice Neurology is hosting a new series of Facebook Live events this month – COVID-19: Roadmap to Reopening. Jeffrey Gelblum, MD kicked off the series yesterday presenting “Re-engaging Older Loved Ones”. He talked about the coronavirus pandemic and endemic. Dr. Gelblum talks about the components of infectivity (Ro): 1. Duration – how long are …

COVID-19: Roadmap to Reopening Read More »

Translate »